Distribution of Microbes and Drug Susceptibility in Patients with Diabetic Foot Infections in Southwest China
Open Access
- 5 August 2018
- journal article
- research article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2018, 1-9
Abstract
Objective. To investigate the microbial distribution and drug susceptibility among diabetic foot ulcers (DFUs) with different Wagner grades and between acute and chronic DFUs. Methods. We enrolled 428 DFU patients who were hospitalized and treated in the Southwest Hospital. We collected deep ulcer secretion for microbial culture and drug susceptibility tests and analyzed the results. We reexamined 67 patients with poor anti-infection efficacy and analyzed microbial species. Results: The 354 positive samples included 201 cases (56.8%) of single-pathogen infections and 153 cases (43.2%) of multiple-pathogen infections before antibiotic therapy. A total of 555 strains were cultivated, including 205 (36.9%) strains of gram-positive organisms (GPOs), 283 (51.0%) gram-negative bacilli (GNB), and 67 (12.1%) fungal strains. In terms of distribution, patients with different Wagner grades had different bacterial composition ratios (). Patients with Wagner grades 3–5 mainly had GNB. The specimens from chronic ulcer wounds were primarily GNB (54.2%), whereas fungi accounted for 14.4% of the infections; the distribution was significantly different from that of acute ulcers (). The susceptibility tests showed that the Staphylococcus genus was more susceptible to vancomycin, linezolid, and tigecycline. Tobramycin was the most effective drug (97%) for the treatment of Escherichia coli, followed by ertapenem (96.4%), imipenem (93.5%), and cefotetan (90%). Most of the remaining GNB were susceptible to antibiotics such as carbapenems, aminoglycosides, fluoroquinolones, ceftazidime, cefepime, and piperacillin-tazobactam (>63.2%). After antibiotic therapy, the positive rate of microbial culture was 52.2%, and the proportion of GNB and fungi increased to 68.9% and 20%. Conclusion. The distribution and types of bacteria in diabetic foot infection (DFI) patients varied with the different Wagner classification grades, courses of the ulcers, and antibiotic therapy. Multidrug resistance were increased, and the clinical treatment of DFIs should select the most suitable antibiotics based on the pathogen culture and drug susceptibility test results.
Keywords
Funding Information
- National Natural Science Foundation of China (81670711)
This publication has 28 references indexed in Scilit:
- Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populationsJournal of Microbiology, Immunology and Infection, 2018
- Bacterial Prevalence and Antibiotic Resistance in Clinical Isolates of Diabetic Foot Ulcers in the Northeast of Tamaulipas, MexicoThe International Journal of Lower Extremity Wounds, 2017
- Bacterial Contribution in Chronicity of WoundsMicrobial Ecology, 2016
- Clinical Characteristics and Risk Factors of Diabetic Foot Ulcer With Multidrug-Resistant Organism InfectionThe International Journal of Lower Extremity Wounds, 2014
- Risk Factors and Gene Type for Infections of MRSA in Diabetic Foot Patients in Tianjin, ChinaThe International Journal of Lower Extremity Wounds, 2013
- Cost of treating diabetic foot ulcers in five different countriesDiabetes/Metabolism Research and Reviews, 2012
- Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospitalDiabetes Research and Clinical Practice, 2011
- A Clinico-microbiological Study of Diabetic Foot Ulcers in an Indian Tertiary Care HospitalDiabetes Care, 2006
- Preventing Foot Ulcers in Patients With DiabetesJAMA, 2005
- Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impactDiabetic Medicine, 2004